Marianna Mela1, Wendy Smeeton1, Susan E Davies2, Elena Miranda3, Cinzia Scarpini4, Nick Coleman4, Graeme J M Alexander5. 1. Division of Gastroenterology and Hepatology, University Department of Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom. 2. Department of Histopathology, Addenbrooke's Hospital, Cambridge, United Kingdom. 3. Department of Biology and Biotechnologies, Charles Darwin and Pasteur Institute Cenci-Bolognetti Foundation, Sapienza University of Rome, Rome, Italy. 4. Department of Pathology, Cambridge University, Cambridge, United Kingdom. 5. UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, United Kingdom.
Abstract
BACKGROUND: Alpha-1 antitrypsin deficiency (AATD) is an important, inherited cause of chronic liver disease. Marked variation in fibrosis stages in patients with homozygous deficiency and those factors that determine whether heterozygous carriers develop liver fibrosis, remain unexplained. Murine studies implicate polymerized alpha-1 antitrypsin (AAT) within hepatocytes as pathogenic. AIMS AND METHODS: The relationship between the quantity of polymerized AAT within hepatocytes (polymer load), stage of hepatic fibrosis and liver-related clinical outcomes (death, evolution to hepatocellular carcinoma, or need for liver transplantation) were investigated using liver tissue from 92 patients at first presentation with either homozygous or heterozygous AATD. Further tissue-based studies were undertaken to determine if polymerized AAT was associated with failure of cell cycle progression, accelerated aging or hepatocyte senescence by immunohistochemical analysis. RESULTS: The AAT polymer load correlated closely with hepatic fibrosis stage and long-term clinical outcome, independent of homozygous or heterozygous status. AAT polymers within hepatocytes correlated closely with failure of cell cycle progression assessed using cell cycle phase markers, accelerated aging manifest as shortened telomeres and other markers consistent with hepatocyte senescence manifest as the presence of nuclear p21 expression and enlarged nuclei. The proportion of p21 positive hepatocytes or hepatocytes with enlarged nuclei correlated with hepatic fibrosis stage and the long-term clinical outcome. CONCLUSION: These data suggest that accumulation of AAT polymers within hepatocytes drives senescence. Quantitation of both the AAT polymer load or hepatocyte senescence markers correlated with hepatic fibrosis stage and the long-term clinical outcome. Either or both could be considered markers of disease severity and treatment response in clinical trials. JCOPDF
BACKGROUND: Alpha-1 antitrypsin deficiency (AATD) is an important, inherited cause of chronic liver disease. Marked variation in fibrosis stages in patients with homozygous deficiency and those factors that determine whether heterozygous carriers develop liver fibrosis, remain unexplained. Murine studies implicate polymerized alpha-1 antitrypsin (AAT) within hepatocytes as pathogenic. AIMS AND METHODS: The relationship between the quantity of polymerized AAT within hepatocytes (polymer load), stage of hepatic fibrosis and liver-related clinical outcomes (death, evolution to hepatocellular carcinoma, or need for liver transplantation) were investigated using liver tissue from 92 patients at first presentation with either homozygous or heterozygous AATD. Further tissue-based studies were undertaken to determine if polymerized AAT was associated with failure of cell cycle progression, accelerated aging or hepatocyte senescence by immunohistochemical analysis. RESULTS: The AAT polymer load correlated closely with hepatic fibrosis stage and long-term clinical outcome, independent of homozygous or heterozygous status. AAT polymers within hepatocytes correlated closely with failure of cell cycle progression assessed using cell cycle phase markers, accelerated aging manifest as shortened telomeres and other markers consistent with hepatocyte senescence manifest as the presence of nuclear p21 expression and enlarged nuclei. The proportion of p21 positive hepatocytes or hepatocytes with enlarged nuclei correlated with hepatic fibrosis stage and the long-term clinical outcome. CONCLUSION: These data suggest that accumulation of AAT polymers within hepatocytes drives senescence. Quantitation of both the AAT polymer load or hepatocyte senescence markers correlated with hepatic fibrosis stage and the long-term clinical outcome. Either or both could be considered markers of disease severity and treatment response in clinical trials. JCOPDF
Authors: Pavel Strnad; Stephan Buch; Karim Hamesch; Jochen Hampe; Thomas Berg; Christian Trautwein; Janett Fischer; Jonas Rosendahl; Renate Schmelz; Stefan Brueckner; Mario Brosch; Carolin V Heimes; Vivien Woditsch; David Scholten; Hans Dieter Nischalke; Sabina Janciauskiene; Mattias Mandorfer; Michael Trauner; Michael J Way; Andrew McQuillin; Matthias C Reichert; Marcin Krawczyk; Markus Casper; Frank Lammert; Felix Braun; Witigo von Schönfels; Sebastian Hinz; Greta Burmeister; Claus Hellerbrand; Andreas Teufel; Alexandra Feldman; Joern M Schattenberg; Heike Bantel; Anita Pathil; Muenevver Demir; Johannes Kluwe; Tobias Boettler; Monika Ridinger; Norbert Wodarz; Michael Soyka; Marcella Rietschel; Falk Kiefer; Thomas Weber; Silke Marhenke; Arndt Vogel; Holger Hinrichsen; Ali Canbay; Martin Schlattjan; Katharina Sosnowsky; Christoph Sarrazin; Johann von Felden; Andreas Geier; Pierre Deltenre; Bence Sipos; Clemens Schafmayer; Michael Nothnagel; Elmar Aigner; Christian Datz; Felix Stickel; Marsha Yvonne Morgan Journal: Gut Date: 2018-08-01 Impact factor: 23.059
Authors: Karim Hamesch; Mattias Mandorfer; Vítor M Pereira; Linda S Moeller; Monica Pons; Grace E Dolman; Matthias C Reichert; Carolin V Schneider; Vivien Woditsch; Jessica Voss; Cecilia Lindhauer; Malin Fromme; Igor Spivak; Nurdan Guldiken; Biaohuan Zhou; Anita Arslanow; Benedikt Schaefer; Heinz Zoller; Elmar Aigner; Thomas Reiberger; Martin Wetzel; Britta Siegmund; Carolina Simões; Rui Gaspar; Luís Maia; Dalila Costa; Mário Bento-Miranda; Josef van Helden; Eray Yagmur; Danilo Bzdok; Jan Stolk; Wolfgang Gleiber; Verena Knipel; Wolfram Windisch; Ravi Mahadeva; Robert Bals; Rembert Koczulla; Miriam Barrecheguren; Marc Miravitlles; Sabina Janciauskiene; Felix Stickel; Frank Lammert; Rodrigo Liberal; Joan Genesca; William J Griffiths; Michael Trauner; Aleksander Krag; Christian Trautwein; Pavel Strnad Journal: Gastroenterology Date: 2019-05-20 Impact factor: 22.682
Authors: Elena Miranda; Juan Pérez; Ugo I Ekeowa; Nedim Hadzic; Noor Kalsheker; Bibek Gooptu; Bernard Portmann; Didier Belorgey; Marian Hill; Susan Chambers; Jeff Teckman; Graeme J Alexander; Stefan J Marciniak; David A Lomas Journal: Hepatology Date: 2010-09 Impact factor: 17.425
Authors: Suman Verma; Phaedra Tachtatzis; Sue Penrhyn-Lowe; Cinzia Scarpini; Diana Jurk; Thomas Von Zglinicki; Nick Coleman; Graeme J M Alexander Journal: Hepatology Date: 2012-08-27 Impact factor: 17.425